Business Description
Balsm Alofoq Medical Co
SIC : 8071
ISIN : SA165GU4MA16
Share Class Description:
SAU:9620: Ordinary SharesDescription
Balsm Alofoq Medical Co is a Saudi Arabian healthcare company operating in the medical services and medical supply sectors. Its activities include the operation of medical services, specialized clinics, and medical complexes, as well as the performance of medical operations. In addition, the company is engaged in the import and supply of medical devices and medical supplies, distributing these products across all regions of the Kingdom of Saudi Arabia. The company serves patients through its clinics and medical complexes while also supplying healthcare providers, hospitals, and other medical institutions with devices and consumables. Its revenue is generated through the provision of clinical and medical services and through the sale and distribution of imported medical equipment and supplies. The company operates primarily within the Saudi Arabian market, where its medical services and distribution activities are concentrated.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.3 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | 0.88 | |||||
Interest Coverage | 13.13 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 8.88 | |||||
Beneish M-Score | 10.32 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 0.74 | |||||
9-Day RSI | 4.65 | |||||
14-Day RSI | 11.68 | |||||
3-1 Month Momentum % | 5.83 | |||||
6-1 Month Momentum % | -14.53 | |||||
12-1 Month Momentum % | -21.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 7.66 | |||||
Quick Ratio | 6.54 | |||||
Cash Ratio | 4.65 | |||||
Days Inventory | 83.06 | |||||
Days Sales Outstanding | 11.3 | |||||
Days Payable | 20.12 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 33.76 | |||||
Operating Margin % | 8.52 | |||||
Net Margin % | 6.48 | |||||
EBITDA Margin % | 15.52 | |||||
FCF Margin % | -21.49 | |||||
OCF Margin % | 2.97 | |||||
ROE % | 4.61 | |||||
ROA % | 3.94 | |||||
ROIC % | 6.48 | |||||
ROC (Joel Greenblatt) % | 11.69 | |||||
ROCE % | 6.05 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 39.3 | |||||
PE Ratio without NRI | 39.3 | |||||
PS Ratio | 2.54 | |||||
PB Ratio | 1.76 | |||||
Price-to-Tangible-Book | 1.76 | |||||
Price-to-Operating-Cash-Flow | 85.49 | |||||
EV-to-EBIT | 22.27 | |||||
EV-to-EBITDA | 13.47 | |||||
EV-to-Revenue | 2.09 | |||||
EV-to-FCF | -9.98 | |||||
Price-to-Graham-Number | 1.75 | |||||
| Price-to-Net-Current-Asset-Value | 3.92 | |||||
| Price-to-Net-Cash | 9.46 | |||||
Earnings Yield (Greenblatt) % | 4.49 | |||||
FCF Yield % | -8.46 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Balsm Alofoq Medical Co Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ï·¼) | 22.038 | ||
| EPS (TTM) (ï·¼) | 0.571 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 20.18 | ||
| 14-Day RSI | 11.68 | ||
| 14-Day ATR (ï·¼) | 12.324371 | ||
| 20-Day SMA (ï·¼) | 23.271 | ||
| 12-1 Month Momentum % | -21.84 | ||
| 52-Week Range (ï·¼) | 22 - 32.25 | ||
| Shares Outstanding (Mil) | 2.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Balsm Alofoq Medical Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Balsm Alofoq Medical Co Stock Events
| Event | Date | Price (ï·¼) | ||
|---|---|---|---|---|
| 2:1 Stock Split | 2025-12-22 | 27.10 (+2.26%) |
Show
Entries
Balsm Alofoq Medical Co Frequently Asked Questions
What is Balsm Alofoq Medical Co(SAU:9620)'s stock price today?
The current price of SAU:9620 is ï·¼22.32. The 52 week high of SAU:9620 is ï·¼32.25 and 52 week low is ï·¼22.00.
When is next earnings date of Balsm Alofoq Medical Co(SAU:9620)?
The next earnings date of Balsm Alofoq Medical Co(SAU:9620) is .
Does Balsm Alofoq Medical Co(SAU:9620) pay dividends? If so, how much?
Balsm Alofoq Medical Co(SAU:9620) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers